aspirin

Generic: aspirin

Labeler: rugby laboratories
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin
Generic Name aspirin
Labeler rugby laboratories
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
Rugby Laboratories

Identifiers & Regulatory

Product NDC 0536-1054
Product ID 0536-1054_073e46e8-4175-46cc-b407-8c173f8b2a1d
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 1996-02-10

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05361054
Hyphenated Format 0536-1054

Supplemental Identifiers

RxCUI
212033
UPC
0305361054298
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (0536-1054-29) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

0536-1054-29 1 BOTTLE, PLASTIC in 1 CARTON (0536-1054-29) / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Aspirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "073e46e8-4175-46cc-b407-8c173f8b2a1d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0305361054298"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["f7ca9f4a-f8ef-46d2-9536-b69541e6653d"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Rugby Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (0536-1054-29)  / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "0536-1054-29", "marketing_start_date": "19960210"}], "brand_name": "Aspirin", "product_id": "0536-1054_073e46e8-4175-46cc-b407-8c173f8b2a1d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0536-1054", "generic_name": "Aspirin", "labeler_name": "Rugby Laboratories", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "19960210", "listing_expiration_date": "20261231"}